Thyroid dysfunction induced by alectinib in a patient with a non-small cell lung cancer

Background: Hypothyroidism is a well-known side effect associated with tyrosine kinase inhibitors (TKIs) therapy. We describe a case of a patient with a history of postsurgical hypothyroidism who presented TSH elevation ranging from 1.68 to 17.09 IU/ml with normal free thyroxine (T4) after starting...

Full description

Bibliographic Details
Main Authors: L. Plaza-Enriquez, M. Sanchez-Valenzuela, F. Henriquez
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Clinical and Translational Endocrinology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214624522000077